Endogenous activation of peroxisome proliferator-activated receptor-α in proximal tubule cells in counteracting phosphate toxicity

被引:0
|
作者
Katsuma, Yusuke [1 ]
Matsui, Isao [1 ,2 ]
Matsumoto, Ayumi [1 ]
Okushima, Hiroki [1 ]
Imai, Atsuhiro [1 ]
Sakaguchi, Yusuke [1 ]
Yamamoto, Takeshi [1 ]
Mizui, Masayuki [1 ]
Uchinomiya, Shohei [3 ]
Kato, Hisakazu [4 ]
Ojida, Akio [3 ]
Takashima, Seiji [4 ]
Inoue, Kazunori [1 ]
Isaka, Yoshitaka [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Nephrol, Osaka, Japan
[2] Osaka Univ, Inst Open & Transdisciplinary Res Initiat, Transdimens Life Imaging Div, Osaka, Japan
[3] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Med Sci, Med Chem & Chem Biol, Fukuoka, Japan
[4] Osaka Univ, Grad Sch Med, Dept Med Biochem, Osaka, Japan
关键词
chronic kidney disease; fibrosis; lipids; phosphate; proximal tubule; KIDNEY FIBROSIS; PPAR; PROTECTS; INFLAMMATION; OXIDATION; INJURY;
D O I
10.1152/ajprenal.00046.2024
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Increased dietary phosphate consumption intensifies renal phosphate burden. Several mechanisms for phosphate-induced renal tubulointerstitial fibrosis have been reported. Considering the dual nature of phosphate as both a potential renal toxin and an essential nutrient for the body, kidneys may possess inherent protective mechanisms against phosphate overload, rather than succumbing solely to injury. However, there is limited understanding of such mechanisms. To identify these mechanisms, we conducted single-cell RNA sequencing (scRNA-seq) analysis of the kidneys of control and dietary phosphate-loaded (Phos) mice at a time point when the Phos group had not yet developed tubulointerstitial fibrosis. scRNA-seq analysis identified the highest number of differentially expressed genes in the clusters belonging to proximal tubular epithelial cells (PTECs). Based on these differentially expressed genes, in silico analyses suggested that the Phos group activated peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and fatty acid beta-oxidation (FAO) in the PTECs. This activation was further substantiated through various experiments, including the use of an FAO activity visualization probe. Compared with wild-type mice, Ppara knockout mice exhibited exacerbated tubulointerstitial fibrosis in response to phosphate overload. Experiments conducted with cultured PTECs demonstrated that activation of the PPAR-alpha/FAO pathway leads to improved cellular viability under high-phosphate conditions. The Phos group mice showed a decreased serum concentration of free fatty acids, which are endogenous PPAR-alpha agonists. Instead, experiments using cultured PTECs revealed that phosphate directly activates the PPAR-alpha/FAO pathway. These findings indicate that noncanonical metabolic reprogramming via endogenous activation of the PPAR-alpha/FAO pathway in PTECs is essential to counteract phosphate toxicity.
引用
收藏
页码:F208 / F223
页数:16
相关论文
共 50 条
  • [41] Activation of peroxisome proliferator-activated receptor-α (PPARα) in proximal intestine improves postprandial lipidemia in obese diabetic KK-Ay mice
    Kimura, Rino
    Takahashi, Nobuyuki
    Goto, Tsuyoshi
    Murota, Kaeko
    Kawada, Teruo
    OBESITY RESEARCH & CLINICAL PRACTICE, 2013, 7 (05) : E353 - E360
  • [42] Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice
    Balandaram, Gayathri
    Kramer, Lance R.
    Kang, Boo-Hyon
    Murray, Lain A.
    Perdew, Gary H.
    Gonzalez, Frank J.
    Peters, Jeffrey M.
    TOXICOLOGY, 2016, 363 : 1 - 9
  • [43] Peroxisome Proliferator-Activated Receptor-γ Activation Prevents Sepsis-Related Cardiac Dysfunction and Mortality In Mice
    Drosatos, Konstantinos
    Khan, Raffay S.
    Trent, Chad M.
    Jiang, Hongfeng
    Son, Ni-Huiping
    Blaner, William S.
    Homma, Shunichi
    Schulze, P. Christian
    Goldberg, Ira J.
    CIRCULATION-HEART FAILURE, 2013, 6 (03) : 550 - +
  • [44] Prevention of local lipotoxicity: a new renoprotective mechanism of peroxisome proliferator-activated receptor-α activation in hypertension and obesity?
    Zhao, Xueying
    HYPERTENSION RESEARCH, 2009, 32 (10) : 821 - 823
  • [45] Expression of Peroxisome Proliferator-activated Receptor-γ in the Kidneys of Cats with Chronic Kidney Disease
    Yabuki, A.
    Uehara, Y.
    Ichii, O.
    Yoshida, C.
    Yamato, O.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2020, 176 : 81 - 85
  • [46] Evidence for the Role of Peroxisome Proliferator-Activated Receptor-β/δ in the Development of Spinal Cord Injury
    Paterniti, Irene
    Esposito, Emanuela
    Mazzon, Emanuela
    Galuppo, Maria
    Di Paola, Rosanna
    Bramanti, Placido
    Kapoor, Amar
    Thiemermann, Christoph
    Cuzzocrea, Salvatore
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (02) : 465 - 477
  • [47] Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-γ agonist in hypercholesterolemia
    Tao, L
    Liu, HR
    Gao, E
    Teng, ZP
    Lopez, BL
    Christopher, TA
    Ma, XL
    Batinic-Haberle, I
    Willette, RN
    Ohlstein, EH
    Yue, TL
    CIRCULATION, 2003, 108 (22) : 2805 - 2811
  • [48] Protective Role of Peroxisome Proliferator-Activated Receptor-γ in the Development of Intracranial Aneurysm Rupture
    Shimada, Kenji
    Furukawa, Hajime
    Wada, Kosuke
    Korai, Masaaki
    Wei, Yuan
    Tada, Yoshiteru
    Kuwabara, Atsushi
    Shikata, Fumiaki
    Kitazato, Keiko T.
    Nagahiro, Shinji
    Lawton, Michael T.
    Hashimoto, Tomoki
    STROKE, 2015, 46 (06) : 1664 - +
  • [49] Peroxisome proliferator-activated receptor-γ agonists attenuate biofilm formation by Pseudomonas aeruginosa
    Bedi, Brahmchetna
    Maurice, Nicholas M.
    Ciavatta, Vincent T.
    Lynn, K. Sabrina
    Yuan, Zhihong
    Molina, Samuel A.
    Joo, Myungsoo
    Tyor, William R.
    Goldberg, Joanna B.
    Koval, Michael
    Hart, C. Michael
    Sadikot, Ruxana T.
    FASEB JOURNAL, 2017, 31 (08) : 3608 - 3621
  • [50] Peroxisome proliferator-activated receptor-α enhances lipid metabolism in a skin equivalent model
    Rivier, M
    Castiel, I
    Safonova, I
    Ailhaud, G
    Michel, S
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (04) : 681 - 687